These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 3459391)

  • 61. Successful therapy of experimental endocarditis caused by vancomycin-resistant Staphylococcus aureus with a combination of vancomycin and beta-lactam antibiotics.
    Fox PM; Lampen RJ; Stumpf KS; Archer GL; Climo MW
    Antimicrob Agents Chemother; 2006 Sep; 50(9):2951-6. PubMed ID: 16940087
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Studies of RP 59500 in vitro and in a rabbit model of aortic valve endocarditis caused by methicillin-resistant Staphylococcus aureus.
    Chambers HF
    J Antimicrob Chemother; 1992 Jul; 30 Suppl A():117-22. PubMed ID: 1399943
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Efficacy of linezolid alone or in combination with vancomycin for treatment of experimental endocarditis due to methicillin-resistant Staphylococcus aureus.
    Chiang FY; Climo M
    Antimicrob Agents Chemother; 2003 Sep; 47(9):3002-4. PubMed ID: 12937013
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Methicillin-resistant Staphylococcus aureus.
    Morris JG; Tenney JH
    Ann Intern Med; 1983 Aug; 99(2):283-4. PubMed ID: 6881798
    [No Abstract]   [Full Text] [Related]  

  • 65. Lysostaphin treatment of experimental aortic valve endocarditis caused by a Staphylococcus aureus isolate with reduced susceptibility to vancomycin.
    Patron RL; Climo MW; Goldstein BP; Archer GL
    Antimicrob Agents Chemother; 1999 Jul; 43(7):1754-5. PubMed ID: 10390235
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Efficacy of trovafloxacin, a new quinolone antibiotic, in experimental staphylococcal endocarditis due to oxacillin-resistant strains.
    Bayer AS; Li C; Ing M
    Antimicrob Agents Chemother; 1998 Jul; 42(7):1837-41. PubMed ID: 9661030
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Fosfomycin plus β-Lactams as Synergistic Bactericidal Combinations for Experimental Endocarditis Due to Methicillin-Resistant and Glycopeptide-Intermediate Staphylococcus aureus.
    del Río A; García-de-la-Mària C; Entenza JM; Gasch O; Armero Y; Soy D; Mestres CA; Pericás JM; Falces C; Ninot S; Almela M; Cervera C; Gatell JM; Moreno A; Moreillon P; Marco F; Miró JM;
    Antimicrob Agents Chemother; 2016 Jan; 60(1):478-86. PubMed ID: 26525803
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Single- and combination-antibiotic therapy for experimental endocarditis caused by methicillin-resistant Staphylococcus aureus.
    Rodríguez A; Vicente MV; Olay T
    Antimicrob Agents Chemother; 1987 Sep; 31(9):1444-5. PubMed ID: 3674852
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Comparative evaluation of daptomycin (LY146032) and vancomycin in the treatment of experimental methicillin-resistant Staphylococcus aureus osteomyelitis in rabbits.
    Mader JT; Adams K
    Antimicrob Agents Chemother; 1989 May; 33(5):689-92. PubMed ID: 2546488
    [TBL] [Abstract][Full Text] [Related]  

  • 70. In vivo efficacy of ceftaroline (PPI-0903), a new broad-spectrum cephalosporin, compared with linezolid and vancomycin against methicillin-resistant and vancomycin-intermediate Staphylococcus aureus in a rabbit endocarditis model.
    Jacqueline C; Caillon J; Le Mabecque V; Miègeville AF; Hamel A; Bugnon D; Ge JY; Potel G
    Antimicrob Agents Chemother; 2007 Sep; 51(9):3397-400. PubMed ID: 17591849
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Trovafloxacin in combination with vancomycin against penicillin-resistant pneumococci in the rabbit meningitis model.
    Rodoni D; Hänni F; Gerber CM; Cottagnoud M; Neftel K; Täuber MG; Cottagnoud P
    Antimicrob Agents Chemother; 1999 Apr; 43(4):963-5. PubMed ID: 10103211
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Community-acquired methicillin-resistant Staphylococcus aureus endocarditis in the Detroit Medical Center.
    Levine DP; Cushing RD; Jui J; Brown WJ
    Ann Intern Med; 1982 Sep; 97(3):330-8. PubMed ID: 7114630
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Influence of reduced susceptibility to glycopeptides on activities of vancomycin and teicoplanin against Staphylococcus aureus in experimental endocarditis.
    Pavie J; Lefort A; Ploy MC; Massias L; Chau F; Garry L; Denis F; Fantin B
    Antimicrob Agents Chemother; 2003 Jun; 47(6):2018-21. PubMed ID: 12760890
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Successful treatment with moxifloxacin of experimental aortic valve endocarditis due to methicillin-resistant Staphylococcus aureus (MRSA).
    Galani L; Pefanis A; Sakka V; Iliopoulos D; Donta I; Triantafyllidi H; Skiadas I; Karayiannakos P; Giamarellou H
    Int J Antimicrob Agents; 2009 Jan; 33(1):65-9. PubMed ID: 18818055
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Therapy for experimental endocarditis due to Staphylococcus epidermidis.
    Kobasa WD; Kaye KL; Shapiro T; Kaye D
    Rev Infect Dis; 1983; 5 Suppl 3():S533-7. PubMed ID: 6635444
    [TBL] [Abstract][Full Text] [Related]  

  • 76. [Teicoplanin versus cloxacillin, cloxacillin-gentamycin and vancomycin in the treatment of experimental endocarditis caused by methicillin-sensitive Staphylococcus aureus].
    Apellaniz G; Valdés M; Pérez R; Martín-Luengo F; García A; Soria F; Gómez J
    Enferm Infecc Microbiol Clin; 1991 Apr; 9(4):208-10. PubMed ID: 1830757
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Comparison of the effectiveness of various antibiotics in the treatment of methicillin-susceptible Staphylococcus aureus experimental infective endocarditis.
    Apellaniz G; Valdés M; Perez R; Martin F; Soria F; Garcia A; Gòmez J; Vicente T
    J Chemother; 1991 Apr; 3(2):91-7. PubMed ID: 1875239
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Treatment of experimental endocarditis due to erythromycin-susceptible or -resistant methicillin-resistant Staphylococcus aureus with RP 59500.
    Entenza JM; Drugeon H; Glauser MP; Moreillon P
    Antimicrob Agents Chemother; 1995 Jul; 39(7):1419-24. PubMed ID: 7492078
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Ciprofloxacin therapy of experimental endocarditis caused by methicillin-resistant Staphylococcus epidermidis.
    Rouse MS; Wilcox RM; Henry NK; Steckelberg JM; Wilson WR
    Antimicrob Agents Chemother; 1990 Feb; 34(2):273-6. PubMed ID: 2327776
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Vancomycin therapy for methicillin-resistant Staphylococcus aureus.
    Sorrell TC; Packham DR; Shanker S; Foldes M; Munro R
    Ann Intern Med; 1982 Sep; 97(3):344-50. PubMed ID: 7114631
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.